Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03439267 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of Coronary Calcium Screening, in Preventing Future Major Adverse Cardiac Events

Study acronym: CorCal
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date changed from estimate of May 2026 to Apr 6, 2026
    • Study completion date: May 2027 to Apr 6, 2027
    v11
  2. Primary completion date: Aug 2024 to May 2026v10 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 9000 to confirmed 5765
    • Study completion date: Aug 2024 to May 2027
    • Site details revised
  3. Primary and study completion dates: Apr 2024 to Aug 2024v9
  4. Re-verified, no change to tracked fieldsv8
  5. Primary and study completion dates: Apr 2023 to Apr 2024
    • Study description expanded, about 30 words
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Enrollment target: 18000 to 9000
    • Eligibility criteria shortened, about 91 words
    • Study description expanded, about 12 words
    v6
  2. Re-verified, no change to tracked fieldsv5
  3. Start date changed from estimate of Apr 2018 to Mar 26, 2018v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v3
  5. Study description expanded, about 9 words
    • Eligibility criteria expanded, about 4 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective of this study is to test the effectiveness of a proactive cardiovascular primary prevention strategy, with or without the use of coronary calcium screening, compared to current standard care, in preventing future major adverse cardiac events (MACE), including all-cause death, non-fatal myocardial infarction (MI), stroke, or any arterial revascularization among a moderate risk population with no current evidence of cardiovascular disease.
Trial Details
NCT Number NCT03439267
Lead Sponsor Intermountain Health Care, Inc.
Conditions
(from sponsor)		 Cardiovascular Primary Prevention Strategy
Enrollment 5,765 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov